Apigenin and Abivertinib, a novel BTK inhibitor synergize to inhibit diffuse large B-cell lymphoma in vivo and vitro

Background: Apigenin, a flavonoid phytochemical extracted from fruits and vegetables, has shown anti-neoplastic effects in a variety of malignant tumors. DLBCL is the most common type of aggressive lymphoma in adults with a poor prognosis. Small-molecule inhibitors like BTK inhibitors have demonstra...

詳細記述

保存先:
書誌詳細
出版年:J Cancer
主要な著者: Huang, Shujuan, Yu, Mengxia, Shi, Nana, Zhou, Yile, Li, Fengling, Li, Xia, Huang, Xin, Jin, Jie
フォーマット: Artigo
言語:Inglês
出版事項: Ivyspring International Publisher 2020
主題:
Research Paper
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7052937/
https://ncbi.nlm.nih.gov/pubmed/32127939
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.34981
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料